Literature DB >> 8694581

Antiubiquitin antibody in localised and systemic scleroderma.

M Fujimoto1, S Sato, H Ihn, K Kikuchi, T Tamaki, K Tamaki, K Takehara.   

Abstract

OBJECTIVE: To determine the presence of antiubiquitin antibody (AUbA) in localised scleroderma and systemic sclerosis, as it is frequently found in the sera of patients with systemic lupus erythematosus (SLE) and has also been shown to have a close relationship with antihistone antibodies that have an important role in scleroderma.
METHODS: Serum samples from patients with localised scleroderma (n = 48) and systemic sclerosis (n = 52) were examined by enzyme linked immunosorbent assay. Twenty samples from patients with SLE, 20 from patients with dermatomyositis, and 30 samples from healthy individuals were used as controls.
RESULTS: AUbA was demonstrated in 44% of patients with localised scleroderma and in 42% of those with systemic sclerosis. The presence of AUbA correlated with the presence of antihistone antibodies in both localised scleroderma and systemic sclerosis.
CONCLUSIONS: AUbA is frequently present in patients with localised scleroderma and systemic sclerosis. Induction of AUbA is closely associated with that of antihistone antibodies, suggesting that ubiquitinated histone may be the target in autoimmune responses of these disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694581      PMCID: PMC1010193          DOI: 10.1136/ard.55.6.399

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

3.  The ubiquitinated histone species are enriched in histone H1-depleted chromatin regions.

Authors:  J R Davie; B E Nickel
Journal:  Biochim Biophys Acta       Date:  1987-08-25

Review 4.  Stress proteins, autoimmunity, and autoimmune disease.

Authors:  J B Winfield; W N Jarjour
Journal:  Curr Top Microbiol Immunol       Date:  1991       Impact factor: 4.291

5.  Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.

Authors:  V D Steen; D L Powell; T A Medsger
Journal:  Arthritis Rheum       Date:  1988-02

6.  Presence of antibodies to ubiquitin during the autoimmune response associated with systemic lupus erythematosus.

Authors:  S Muller; J P Briand; M H Van Regenmortel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases.

Authors:  V Manetto; G Perry; M Tabaton; P Mulvihill; V A Fried; H T Smith; P Gambetti; L Autilio-Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  Autoantibodies to the heat-shock protein hsp73 in localized scleroderma.

Authors:  M Fujimoto; S Sato; H Ihn; K Takehara
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

10.  A branched, synthetic octapeptide of ubiquitinated histone H2A as target of autoantibodies.

Authors:  S Plaué; S Muller; M H van Regenmortel
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  4 in total

1.  Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis.

Authors:  M Fujimoto; M Shimozuma; N Yazawa; M Kubo; H Ihn; S Sato; T Tamaki; K Kikuchi; K Tamaki
Journal:  Ann Rheum Dis       Date:  1997-11       Impact factor: 19.103

Review 2.  Death, autoantigen modifications, and tolerance.

Authors:  P J Utz; T J Gensler; P Anderson
Journal:  Arthritis Res       Date:  2000-02-09

Review 3.  Does antigen masking by ubiquitin chains protect from the development of autoimmune diseases?

Authors:  Robert Weil
Journal:  Front Immunol       Date:  2014-06-03       Impact factor: 7.561

Review 4.  Ubiquitination in Scleroderma Fibrosis and Its Treatment.

Authors:  Ying Long; Weilin Chen; Qian Du; Xiaoxia Zuo; Honglin Zhu
Journal:  Front Immunol       Date:  2018-10-17       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.